Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$7.9M
+585.9% from 2023
Prescriptions
434
$18,100.05 per claim
Patients
106
124 prescribers
Total spending, 2024
$7.9M
$74,107.75 per patient
Medicare prescription drug plans paid $7.9M for Vanflyta in 2024, for 434 prescriptions and refills to 106 patients (up 585.9% from 2023). The average cost per claim was $18,100.05.
Florida had the highest Medicare cost for Vanflyta in 2024: $2.0M for 103 claims, followed by California ($625K).
Rami S Komrokji, hematology-oncology in Tampa, FL, had the highest Medicare cost for Vanflyta in 2024: 13 claims costing $390K.
Vanflyta is made by Daiichi Sankyo Company, Limited (4568.T), listed in the Medicare spending data as Daiichi Sankyo,.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rami S Komrokji Tampa, FL | Hematology-Oncology | 13 | Under 11 | $390K |
| Gabriel N Mannis Stanford, CA | Hematology-Oncology | 11 | Under 11 | $297K |
| Thomas W Leblanc |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 29 | 61 | 24 | $1.1M |
| 2024 | 124 | 434 | 106 | $7.9M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 13 |
| Under 11 |
| $296K |
| Lizamarie Bachier-Rodriguez Philadelphia, PA | Hematology-Oncology | 13 | Under 11 | $249K |
| Alexis M Cruz-Chacon San Juan, PR | Hematology-Oncology | 16 | Under 11 | $243K |
| David Swoboda Tampa, FL | Hematology | 17 | Under 11 | $231K |
| Zeina A Al-Mansour Gainesville, FL | Hematology-Oncology | 11 | Under 11 | $198K |
| Spending |
|---|
| Daiichi Sankyo, 4568.T | 434 | $7.9M |